BARCELONA, Spain — For the first five months of 2007, the future of the Codelink bioarray platform looked bleak. GE Healthcare had pledged to help customers adopt other platforms, and shutter the business and sell off its assets should a buyer not be found. Then, a last-minute deal with Applied Microarrays in April secured the future of the platform.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.